World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
68
Citations
14415
World Ranking
7905
National Ranking
3587

Overview

Michael Chorev is affiliated with Harvard University in the United States. Their research spans multiple disciplines with a focus on medicine and biochemistry, genetics, and molecular biology. Within these broader fields, they have addressed subfields such as molecular biology, oncology, public health, environmental and occupational health, epidemiology, and cell biology.

The primary topics of their work include bone health and treatments, research on leishmaniasis studies, investigations into Trypanosoma species and their implications, studies concerning biotin and related compounds, as well as RNA regulation and disease, RNA and protein synthesis mechanisms, and biochemical and molecular research.

Among the most frequent venues where Michael Chorev has published are:

  • IUPHAR/BPS Guide to Pharmacology CITE
  • Bioorganic & Medicinal Chemistry Letters
  • Preprints.org
  • Pathogens

They have collaborated repeatedly with several researchers, including Alessandro Bisello, Peter A. Friedman, Tom Gardella, Rebecca Hills, and Harald Jüeppner.

Recent publications by Michael Chorev include:

  • Role of symmetry in 3,3-diphenyl-1,3-dihydroindol-2-one derivatives as inhibitors of translation initiation (2022, Bioorganic & Medicinal Chemistry Letters)
  • Parathyroid hormone receptors in GtoPdb v.2023.1 (2023, IUPHAR/BPS Guide to Pharmacology CITE)
  • Activity of the Di-Substituted Urea-Derived Compound I-17 in Leishmania Infections (2023, Preprints.org)
  • Activity of the Di-Substituted Urea-Derived Compound I-17 in Leishmania In Vitro Infections (2024, Pathogens)
  • Parathyroid hormone receptors in GtoPdb v.2021.2 (2021, IUPHAR/BPS Guide to Pharmacology CITE)

The scientist's research into bone health and treatments is reflected in their multiple publications related to parathyroid hormone receptors and related pharmacological databases. Their studies on leishmaniasis and Trypanosoma species contribute to understanding infectious diseases at a molecular and cellular level.

Their work also encompasses the biochemical study of molecular mechanisms including RNA regulation, protein synthesis, and the roles of biotin-related compounds, indicating a multidisciplinary approach intersecting molecular biology, medicine, and pharmacology.

Best Publications

  • Small-Molecule Inhibition of the Interaction between the Translation Initiation Factors eIF4E and eIF4G

    Nathan J. Moerke;Huseyin Aktas;Han Chen;Sonia Cantel

  • On the Concept of Linear Modified Retro-Peptide Structures

    Murray Goodman;Michael Chorev

  • Highly selective agonists for substance P receptor subtypes.

    U. Wormser;R. Laufer;Y. Hart;M. Chorev

  • A dozen years of retro-inverso peptidomimetics

    Michael Chorev;Murray Goodman

  • Novel Dual Inhibitors of AChE and MAO Derived from Hydroxy Aminoindan and Phenethylamine as Potential Treatment for Alzheimer's Disease.

    Jeffrey Sterling;Yaacov Herzig;Tamar Goren;Nina Finkelstein

  • Recent developments in retro peptides and proteins — an ongoing topochemical exploration

    Michael Chorev;Murray Goodman

  • Backbone cyclization: A new method for conferring conformational constraint on peptides

    C Gilon;D Halle;M Chorev;Z Selinger

  • Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity.

    I. Bab;D. Gazit;M. Chorev;A. Muhlrad

  • Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonized by enkephalin.

    Ralph Laufer;Uri Wormser;Zeev Y. Friedman;Chaim Gilon

  • Styryl compounds which inhibit EGF receptor protein tyrosine kinase

    Alexander Levitzki;Chaim Gilon;Michael Chorev;Aviv Gazit

  • Synthesis and conformational analysis of a cyclic peptide obtained via i to i+4 intramolecular side-chain to side-chain azide-alkyne 1,3-dipolar cycloaddition.

    Sonia Cantel;Alexandra Le Chevalier Isaad;Mario Scrima;Jay J Levy

  • Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice

    J. M. Alexander;I. Bab;I. Bab;S. Fish;R. Müller

  • Glycation Inactivation of the Complement Regulatory Protein CD59: A Possible Role in the Pathogenesis of the Vascular Complications of Human Diabetes

    Xuebin Qin;Allison Goldfine;Nicole Krumrei;Luciano Grubissich

  • Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy.

    Serge L. Ferrari;Vered Behar;Michael Chorev;Michael Rosenblatt

  • Novel Arylsulfoanilide−Oxindole Hybrid as an Anticancer Agent That Inhibits Translation Initiation

    Amarnath Natarajan;Yuhong Guo;Frederick Harbinski;Yun Hua Fan

  • Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies.

    Alessandro Bisello;Amy E. Adams;Dale F. Mierke;Dale F. Mierke;Maria Pellegrini

  • Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor.

    Vered Behar;Alessandro Bisello;Gal Bitan;Michael Rosenblatt

  • The bovine renal parathyroid hormone (PTH) receptor has equal affinity for two different amino acid sequences: the receptor binding domains of PTH and PTH-related protein are located within the 14-34 region.

    Michael P. Caulfield;Roberta L. McKEE;Mark E. Goldman;Le T. Duong

  • Characterization of a neurokinin B receptor site in rat brain using a highly selective radioligand.

    R Laufer;C Gilon;M Chorev;Z Selinger

  • Histone H4-related osteogenic growthpeptide (OGP): a novelcirculating stimulator ofosteoblastic activity

    Michael Chorev;Arnold Kahn

Frequent Co-Authors

Michael Rosenblatt
Michael Rosenblatt MSD (United States)
Chaim Gilon
Chaim Gilon Hebrew University of Jerusalem
Zvi Selinger
Zvi Selinger Hebrew University of Jerusalem
Dale F. Mierke
Dale F. Mierke Dartmouth College
Gerhard Wagner
Gerhard Wagner Harvard University
Paolo Rovero
Paolo Rovero University of Florence
Alexander Levitzki
Alexander Levitzki Hebrew University of Jerusalem
Dan Gazit
Dan Gazit Cedars-Sinai Medical Center
Ralph Müller
Ralph Müller ETH Zurich
Dan Gibson
Dan Gibson Hebrew University of Jerusalem

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in Biology and Biochemistry may find a wealth of complimentary career opportunities through online education. For those seeking to enter the health sciences quickly, a 2 year nutrition degree online offers a fast-track route to roles in dietary consultation and wellness industries.

If you aspire to leadership roles in healthcare, pursuing the cheapest online mba healthcare management can equip you with essential business and management skills tailored to medical environments, often at an affordable cost.

For those more interested in the administrative side of medicine, understanding medical coding certification options—such as CPC and CCS—is crucial when evaluating career direction, certification costs, and salary potential.

Lastly, research the medical coder salary expectations and career path to see how your background in biology or biochemistry can be leveraged in health information roles. These online pathways broaden the scope for science students to diversify their skills and prepare for in-demand careers.

Best Scientists Citing Michael Chorev

Trending Scientists

Recently Published Articles